Similar increased serum dipeptidyl peptidase IV activity in chronic hepatitis C and other viral infections

被引:39
作者
Andrieu, T
Thibault, V
Malet, I
Laporte, J
Bauvois, B
Agut, H
Cahour, A [1 ]
机构
[1] Grp Hosp Pitie Salpetriere, CERVI, Virol Lab, UPRES EA 2387, F-75651 Paris 13, France
[2] Inst Curie, INSERM, U365, F-75248 Paris, France
关键词
DPPIV/CD26; HCV; viral infection; fibrosis; cholestasis; pathophysiology;
D O I
10.1016/S1386-6532(02)00128-2
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background; Dipeptidyl peptidase IV is a transmembrane enzyme widely expressed in many cell types, but also present as a soluble form in biological fluids. Its abnormal activity is sometimes associated with liver disease related pathologies. Objectives: The aim of this study was to evaluate the clinical relevance of changes in serum DPPIV activity in hepatitis C and other viral infections. Study design: DPPIV activity was assessed by using a microplate-based colorimetric assay on serum from 88 subjects: 12 healthy uninfected controls, 10 patients with primary biliary cirrhosis (PBC) as a reference group, 36 HCV-infected patients, and patients suffering from viral infections of different etiologies. Levels of DPPIV activity were compared with: (1) those of other serum biochemical parameters such as alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyl transpeptidase (GGT), and bilirubin concentrations; and (2) criteria representative of liver histological status. Results: Compared with healthy subjects, DPPIV activity was significantly increased during viral infections and in PBC (P < 0.01). In HCV-infected patients, the median activity (interquartile range, IQR), 29.78 IU/I (24.66-35.95), differed significantly (P < 0.05) from that of controls: 21.42 (19.76-24.93). No correlation was observed between DPPIV activity and either ALT, AST, bilirubin, or the stage of liver fibrosis and necroinflammatory activity, although GGT was moderately correlated (r = 0.58, P < 0.65). Conclusions: Although we confirmed an elevation of serum DPPIV activity in PBC, it seems to be a non-specific phenomenon common to viral infections. The absence of correlation between serum DPPIV and markers of liver disease in HCV-infected patients, suggests that this activity originates not only from the liver, but also from other sources such as peripheral blood cells involved in the control of viral infections. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:59 / 68
页数:10
相关论文
共 42 条
[1]  
Antczak C, 2001, BIOESSAYS, V23, P251, DOI 10.1002/1521-1878(200103)23:3<251::AID-BIES1035>3.3.CO
[2]  
2-F
[3]  
Antczak C, 2001, J BIOL REG HOMEOS AG, V15, P130
[4]   MURINE THYMOCYTES POSSESS SPECIFIC CELL SURFACE-ASSOCIATED EXOAMINOPEPTIDASE ACTIVITIES - PREFERENTIAL EXPRESSION BY IMMATURE CD4-CD8- SUBPOPULATION [J].
BAUVOIS, B .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (03) :459-468
[5]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[6]   Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? [J].
Bertoletti, A ;
Maini, MK .
CURRENT OPINION IN MICROBIOLOGY, 2000, 3 (04) :387-392
[7]   Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence [J].
Cerny, A ;
Chisari, FV .
HEPATOLOGY, 1999, 30 (03) :595-601
[8]   PURIFICATION AND PROPERTIES OF DIPEPTIDYL PEPTIDASE-IV FROM HUMAN URINE [J].
CHIKUMA, T ;
HAMA, T ;
NAGATSU, T ;
KUMEGAWA, M ;
KATO, T .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (04) :325-330
[9]   Analysis of a successful immune response against hepatitis C virus [J].
Cooper, S ;
Erickson, AL ;
Adams, EJ ;
Kansopon, J ;
Weiner, AJ ;
Chien, DY ;
Houghton, M ;
Parham, P ;
Walker, CM .
IMMUNITY, 1999, 10 (04) :439-449
[10]   CD26, let it cut or cut it down [J].
De Meester, I ;
Korom, S ;
Van Damme, J ;
Scharpé, S .
IMMUNOLOGY TODAY, 1999, 20 (08) :367-375